Civitas Therapeutics - Ownership and Business Overview

Life ScienceCompany

Civitas Therapeutics Ownership

Who owns Civitas Therapeutics?

Civitas Therapeutics is owned by Acorda Therapeutics. It was acquired on September 24, 2014.

Was Civitas Therapeutics formerly PE-backed?

Yes. Civitas Therapeutics was formerly owned by 1 private investor.

Civitas Therapeutics Business Overview

Where is Civitas Therapeutics headquartered?

Civitas Therapeutics is headquartered in Chelsea, Massachusetts.

What sector is Civitas Therapeutics in?

Civitas Therapeutics is a life science company.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.

Civitas Therapeutics, Inc.

190 Everett Avenue,
Chelsea, Massachusetts 02150
United States,
(617) 660-4110
www.civitastherapeutics.com

Civitas Therapeutics, Inc. is a biopharmaceutical company focused on developing a robust pipeline of inhaled therapeutics with the clinically proven ARCUS® dry powder pulmonary delivery platform.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.